Clinical evaluation of EXTEND absorbable synthetic implants for dry eyes

Haili Li,Shuang Liu,Xiaoming Yan

DOI: https://doi.org/10.3760/cma.j.issn.2095-0160.2009.03.013

2009-01-01

Abstract:Objective Many types of punctual plugs have been developed recent year. This study was to evaluate the clinical efficacy of EXTEND Absorbable Synthetic Implants( EASI) during the treatment of dry eye. Methods Forty-two eyes from 42 patients with mild to moderate aqueous tear deficiency( ATD) dry eyes were chosen from Peking University First Hospital from March through September in 2007. Regular dry eye questionnaire was performed before treatment with EASI and 2 weeks, 1 month and 3 months after treatment. Tear meniscus height(TMH), tear break-up time( BUT), Schirmer I test(ST I) fluorescein and lissamine green staining were carried out for the evaluation of dry eye. Impression cytology(IC) was utilized before treatment and 3 months after treatment. Results The score of dry eye assessment at 2 weeks, 1 month and 3 months after treatment was 2. 60 ± 1. 45, 2. 30 ± 1.46, and 2.37 ± 1.78 respectively, and one before treatment was 3.62 ± 1.53, showing a significant difference among them( F-35. 576, P < 0. 01). These score was obviously improved after the application of EASI. 95. 24% patients(40/42)were satisfied with the management procedure. Compared with pretreatment, TMH was increased(F =36. 371, P <0.01), and corneal fluorescein dye was reduced( F = 12. 088, P < 0. 01), and lissamine green staining( F = 12. 088, P < 0. 01), and TBUT(F = 24. 83, P <0. 01) and elongated scores of ST I( F = 4. 399, P = 0. 006) were increased. The usage times of artificial tears were less( 2. 38 ± 2. 28) than before( 5. 14 ± 2. 50)( F = 10. 308, P < 0. 001). The squamous metaplasia of conjunctival epithelial layer was improved at the 3 months. No serious adverse effect was found during the treatment. Conclusion The application of EASI can relieve the symptoms of dry eye and improve tear volume and tear film stability. The treating approach with EXTEND Absorbable Synthetic Implants is safe and effective for ATD patients.